What is NeoGenomics's price / book?

NeoGenomics (NEO) reported price / book of 1.2× in Q1 2026.

How has NeoGenomics's price / book changed year-over-year?

NeoGenomics's price / book decreased by 15.3% year-over-year, from 1.4× to 1.2×.

What is the long-term trend for NeoGenomics's price / book?

Over 5 years (2020 to 2025), NeoGenomics's price / book has grown at a -27.4% compound annual growth rate (CAGR), from 9× to 1.8×.

What does price / book mean?

Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

NeoGenomics NEO Price / book

Price / book at other companies

Labcorp HoldingsLH

2.5×+0.2×

Quest DiagnosticsDGX

2.9×+0.2×

Personalis, Inc.PSNL

2.6×+1.1×

Guardant HealthGH

36.8×—

Natera, Inc.NTRA

16×+0.6×

Tempus AI, Inc.TEM

19.4×-6.1×

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total equity$828.8M-6.7%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B+86.5%

Enterprise value$1.6B+159%

P/S2.3×+0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Calculated from NeoGenomics’s reported figures.

market cap/total stockholders equity=1.2×

Based on the most recent quarter.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's price / book?: NeoGenomics (NEO) reported price / book of 1.2× in Q1 2026.
How has NeoGenomics's price / book changed year-over-year?: NeoGenomics's price / book decreased by 15.3% year-over-year, from 1.4× to 1.2×.
What is the long-term trend for NeoGenomics's price / book?: Over 5 years (2020 to 2025), NeoGenomics's price / book has grown at a -27.4% compound annual growth rate (CAGR), from 9× to 1.8×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.